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Highlights 
 Pain neuroscience education can facilitate patients’ ability to cope with their 
condition. 
 Pain neuroscience education doesn’t produce clinically significant reductions in pain. 
 Pain neuroscience education doesn’t produce clinically significant reductions in 
disability. 
 Pain neuroscience education does produce clinically significant reductions in 
kinesiophobia. 
 Pain neuroscience education does produce clinically significant reductions in 
catastrophising. 
 
Abstract  
Chronic musculoskeletal pain (CMP) is an urgent global public health concern. Pain 
neuroscience education (PNE) is an intervention used in the management of CMP 
aiming to reconceptualise an individual‟s understanding of their pain as less 
threatening. This mixed-methods review undertook a segregated synthesis of 
quantitative and qualitative studies to investigate the clinical effectiveness, and 
patients‟ experience of, PNE for people with CMP. Electronic databases were 
searched for studies published between 01/01/2002 and 14/06/2018. Twelve 
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randomised controlled trials (n = 755) that reported pain, disability and psychosocial 
outcomes and four qualitative studies (n = 50) that explored patients experience of 
PNE were included. The meta-analysed pooled treatment effects for PNE vs control 
had low clinical relevance in the short-term for pain (-3.20/100; 95%CI -6.66 to 0.27) 
and disability (-4.10/100; 95%CI -7.89 to -0.32) and the medium-term for pain (-
4.22/100; 95%CI -16.44 to 8.01) and disability (-8.23/100; 95%CI -15.61 to -0.84). 
The treatment effect of PNE for kinesiophobia was clinically relevant in the short-
term (-13.55/100; 95%CI -25.89 to -1.21) and for pain catastrophising in the medium-
term (-5.26; 95%CI -10.59 to 0.08). Meta-synthesis of 23 qualitative findings resulted 
in the identification of two synthesized findings that identified several key 
components important for enhancing the patient experience of PNE such as allowing 
the patient to tell their own story. These components can enhance pain 
reconceptualisation, which appears to be an important process to facilitate patients‟ 
ability to cope with their condition. The protocol was published on PROSPERO 
(CRD42017068436). 
Perspective 
We outline the effectiveness of PNE for the management of pain, disability and 
psychosocial outcomes in adults with CMP. Key components that can enhance the 
patient experience of PNE such as allowing the patient to tell their own story are also 
presented. These components may enhance pain reconceptualisation. 
Key words 
Pain; Neuroscience; Education; Chronic; Systematic review 
Introduction 
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Chronic musculoskeletal pain (CMP) affects 20% of adults worldwide14 and is 
considered an urgent global public health concern16.  In addition to the negative 
impact on an individual‟s quality-of-life3,56 there is a large societal financial burden 
associated with CMP. Annual healthcare costs for patients with chronic low back 
pain (CLBP) are double those of matched controls19. In the United Kingdom, The 
National Institute for Health and Care Excellence estimate the direct cost of low back 
pain at over £2.1 billion39. The total cost of CMP is likely to be much higher.  
Interventions which encourage and empower patients to self-manage are 
recommended for individuals with CMP9,13,38,40,55. Education is a cornerstone of this 
approach with the premise that the better an individual understands their condition, 
the more empowered they become and the better they will be able to manage it13,42. 
Given the biopsychosocial nature of CMP, an educational approach grounded in the 
biopsychosocial model would seem an appropriate form of education for people with 
this condition. An increasingly popular form of biopsychosocial education is pain 
neuroscience education (PNE), which has the overarching aim of facilitating 
individuals to reconceptualise their pain as less threatening. Alternative names for 
PNE used within the literature include; explain pain4,33,34; therapeutic neuroscience 
education65; pain biology education43; and pain neurophysiology education7. 
In recent years, there has been an increase in the number and quality of PNE 
reviews. This reflects the rapidly growing quantitative evidence base in the area. 
Many of these reviews show promising results for PNE7,8,26,29,33,47,63,64. The most 
recent review published in English on PNE in heterogeneous CMP concluded that 
the current evidence supports the use of PNE for improving function, pain, 
psychosocial factors, movement, health care utilisation, and pain knowledge29. Two 
recent meta-analysis on patients with CLBP broadly support these findings for pain 
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and disability but not psychosocial factors47,63. However, neither had a registered 
protocol and few of the individual analyses pooled the recommended five or more 
studies22. Additionally, both included studies where the effect was not clearly 
attributable to PNE e.g. PNE + Intervention A Verses Intervention B. To date no 
published review has conducted a meta-analysis on PNE in heterogeneous CMP. 
In addition to a growth in the quantitative literature, in 2016 the first qualitative study 
on PNE was published42. Previous reviews of the literature have focused solely on 
quantitative studies7,8,12,26,29,33,64. The emergence of qualitative studies provides the 
opportunity to undertake a mixed-methods review. Mixed-methods reviews attempt 
to maximise the ability of their findings to inform policy and practice through the 
inclusion of diverse forms of evidence51. 
Review question/objectives 
Review questions were: 
How effective is PNE as an intervention for the management of adults with CMP? 
What are the perceptions of PNE in adults with CMP? This question is delineated 
into the following three objectives: 
1) To explore patient experiences of participating in PNE. 
2) To explore their perceptions of its effectiveness. 
3) To explore how it influenced their understanding of pain.  
Methods 
The Joanna Briggs Institute Reviewers Manual 201752 was used to direct the 
methods of this mixed-methods systematic review and meta-analysis.  
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Inclusion criteria 
 Studies including adults (≥18 years) who have CMP (including chronic lower 
back pain, chronic neck pain, osteoarthritis or rheumatoid arthritis, in addition 
to those who suffer non-specific or widespread musculoskeletal pain 
conditions).  
 Diagnosis of CMP was consistent with the British Pain Society definition 
(chronic pain, which lasts beyond the time that tissue healing would normally 
be expected to have occurred, often taken as ≥3 months49 
 Quantitative studies using a RCT design that (i) compared the intervention 
with no treatment (true control) or usual care (ii) concomitant studies where 
PNE was delivered in addition to another intervention where that other 
intervention was received by both groups and (iii) head-to-head studies where 
PNE was compared to another active intervention. 
 Studies reporting the following objective and subjective measures - primary 
outcomes: pain; any validated measure of pain (numeric rating scale/visual 
analogue scale). Disability; any validated measure of disability (e.g. Roland 
Morris Disability Questionnaire). Secondary outcomes; any validated 
measure, which investigates the individuals‟ physical and/or psychosocial 
wellbeing. 
 Qualitative studies that explored the experiences and perceptions of adults 
with CMP who had received PNE.  
 
Exclusion criteria 
 Studies that included participants with non-musculoskeletal pain such as 
cancer pain, visceral pain or post stroke pain.  
 
Search strategy and selection of studies  
A three-step search strategy was used to identify both published and unpublished 
studies. An initial limited search of MEDLINE and CINAHL was undertaken followed 
by analysis of the text words contained in the title and abstract, and of the index 
terms used. A second search using all identified keywords (Pain AND (Physiology 
OR Neurophysiology OR Neuroscience OR Biology) AND 
Education) and index terms was then undertaken across all included databases (The 
Cochrane Library, AMED, CINAHL Complete, MEDLINE, PsycINFO, PEDro, 
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Scopus, EMBASE, Education Resources Information Centre (ERIC), Web of 
Science, clinicaltrials.gov, dissertations indexed with ProQuest Dissertations and 
Theses Global and EThOS) from 2002-25 July 2017 and updated on 14 June 2018. 
This timeframe was selected as the first PNE study was published in 200232. Finally, 
the reference lists and citing articles of all key identified articles were searched for 
additional studies. (See document, Supplementary Digital Content (SDC) 1 which 
provides the full search strategy). 
After removing duplicates, the title and abstracts were screened by two authors (J.W. 
& D.E. or R.W.). Disagreements were resolved through discussion or a third reviewer 
(D.E. or R.W.). The full-text was obtained for all records that could potentially fit the 
criteria. Upon reading the full-texts those deemed not to meet the inclusion criteria 
were rejected and the rationale recorded. 
Assessment of methodological quality 
Quantitative articles selected for critical appraisal were independently assessed by 
two reviewers (J.W., C.R.) using the Cochrane tool for assessing risk of bias17. 
Qualitative articles were independently assessed by two reviewers (L.C. and either 
J.W or K.C.) using the standardized critical appraisal instrument from the Joanna 
Briggs Institute: Qualitative Assessment and Review Instrument50. As J.W. co-
authored 1 of the qualitative studies23, he did not review this article.  
Where there was insufficient information to make a decision regarding any aspect of 
the critical appraisal the original authors were contacted for further information. 
Disagreements were resolved by discussion or a third reviewer (D.M.). 
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Data extraction 
Stage 1 
Two reviewers (J.W., M.L.) independently extracted the quantitative data using JBI-
SUMARI53 including details about the interventions, populations, study methods and 
outcomes of relevance to the review question/objectives. 
Two reviewers (J.W., L.C.) read each qualitative study, discussed the key themes 
related to the objectives of the review and agreed the level of theme for data 
extraction. Qualitative data were extracted independently (J.W., L.C.) using JBI-
SUMARI53. The data extracted included specific details about the phenomena of 
interest, populations, study methods and outcomes of relevance to the review 
question/objectives. Where possible verbatim data from research participants was 
extracted to illustrate each finding. Where this was not provided in the source papers 
the authors description of the theme was extracted.  
Stage 2 
The results of each single-method synthesis included in the mixed-methods review 
was extracted in numerical, tabular or textual format. Syntheses of quantitative data 
consisted of appropriate elements of the meta-analysis forest plot. For qualitative 
data, it consisted of appropriate elements of the QARI-view table. 
Data synthesis  
This review employed a parallel-results convergent design20 where the quantitative 
and qualitative evidence were analysed and presented separately (Stage 1 of data 
synthesis), otherwise known as a segregated design44. The synthesised findings 
yielded from each separate analysis were complementary as they addressed 
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different aspects of PNE. The final stage of the mixed-methods synthesis (stage 2) 
was configuration, where the complementary findings were juxtaposed and 
organised into a line of argument44,45. 
 
Further details of stage 1 data synthesis for each single-method synthesis: 
The primary statistics extracted from each quantitative study were mean changes in 
pain, disability, pain catastrophising and kinesiophobia for intervention and control 
groups, in addition to the associated standard deviations (SDs) of these changes. 
When a SD of change was not reported, and could not be obtained by contacting the 
authors, it was either calculated from other information given such as standard error, 
or estimated from the baseline and follow up SDs, according to methods described in 
the Cochrane handbook18. Where there was uncertainty a robust data set was used. 
Where possible, treatment effect sizes were pooled in a meta-analysis using 
comprehensive meta-analysis (CMA) software version 3, and double data entry was 
carried out for all results. Pooled effects sizes (and associated 95% confidence 
intervals) were quantified in a weighted fashion using the inverse variance approach. 
I-squared and Tau-squared statistics were used to quantify heterogeneity, and the 
sources of any heterogeneity were explored using meta-regression. 95% prediction 
intervals (representing the likely range of for the pooled mean effect size in a future 
similar RCT) were also calculated according the methods reported by IntHout et al. 
(2016)21. Where statistical pooling was not possible, the findings were presented in 
narrative form including tables and figures to aid in data presentation wherever 
appropriate.  
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Qualitative research findings were pooled using JBI SUMARI software53. This 
involved the aggregation or synthesis of findings to generate a set of statements that 
represent that aggregation. This was achieved by assembling the findings (level 1 
findings) rated according to their quality and categorising these findings based on 
their similarity of meaning (level 2 findings). These categories were then subjected to 
a meta-synthesis generating a single comprehensive set of synthesized findings 
(level 3 findings). Where textual pooling was not possible, the findings were 
presented in a narrative form52. 
Quality of evidence  
The Grades of Recommendation, Assessment, Development and Evaluation 
(GRADE) approach15 was used to rate the overall quality of quantitative evidence for 
each outcome. A Summary of Findings table created using GradePro is presented 
(Table 1). The ConQual approach outlined by Munn et al., (2014)36 based on 
principles of GRADE was used to establish confidence in the qualitative findings. JBI 
levels of credibility (U Unequivocal, C Credible, US Unsupported)52 and 
dependability are presented in a ConQual table (Table 2).  
 
 
 
Results 
Following removal of duplicates, 12,137 publications were identified (Figure 1). Sixty-
three potentially relevant full texts and were evaluated against the inclusion criteria. 
No further studies were found by checking the reference lists or citing articles. Forty-
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three quantitative, two qualitative and one mixed-methods publication were excluded 
at this stage. See document, SDC2 for a list of excluded publications and reasons for 
exclusion.  
For the quantitative component of the review,13 publications reporting data from 12 
RCTs were included2,11,25,27,28,30,31,35,41,48,57,58,60. For the qualitative component of the 
review, 4 publications reporting 4 studies were included23,24,42,61.  
 
 
Methodological quality 
Quantitative studies 
Thirteen publications from 12 RCTs were critically appraised. Quality scores ranged 
from 1-6 out of 7; 7 RCTs scored ≥5 (Table 3; Figure 2 and 3 produced by using 
RevMan software (Review Manager. Version 5.3. Copenhagen: The Nordic 
Cochrane Centre. The Cochrane Collaboration, 2014). 
 
Seven authors were contacted to provide additional information regarding study 
methods, with only one not responding11,28,35,41,48,57,60. The critical appraisal was 
updated accordingly for the six that replied. 
 
 
 
Qualitative studies  
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Four publications were appraised. Quality scores ranged from 4-9 /10. One study 
scored 4/1023 however given this is applied qualitative research, scoring “yes” on 
Q1-5 was inappropriate. Both reviewers (L.C., K.C.) believed the study was 
methodologically sound with appropriate methods applied. Table 4 presents the 
results of the critical appraisal.  
 
Description of quantitative studies  
A summary of all publications are presented in Table 5 
The diagnosis of CMP differed across the 12 RCTs, the most prevalent being CLBP 
(n = 5). There was a total of 755 participants in the sample of 12 included RCTs with 
the number of participants ranging from 12-120. All studies included more women 
than men ranging from 7% male to 46% male. The mean age of participants ranged 
from 37 to 70 years. The mean baseline pain across all studies ranged from 43/100 
to 79/100.  
Studies were conducted in a range of locations including private rehabilitation clinics 
(n = 2) and University facilities (n = 3). Studies were conducted in several countries 
including the USA, Europe and Australia. The duration of educational intervention 
ranged from 0.5 hours to 3 hours. Written information was the main intervention for 
two studies. Participants were given 3 and 6 weeks respectively to read and absorb 
the information. 
PNE was delivered in single and multiple sessions. We defined „multiple‟ as having a 
PNE contact with a member of the study team on more than one occasion via face-
to-face, telephone or email. Written information alone was defined as 1 contact, 
however supporting leaflets/materials were not included when given in addition to 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
 14 
face-face. PNE was delivered in a single session by four studies, and over multiple 
sessions in eight studies.  
Description of qualitative studies 
A summary of all publications are presented in Table 6. Three of the four qualitative 
studies included participants with heterogeneous CMP. The remaining study 
included participants whose primary complaint was CLBP (+/- leg symptoms). Three 
studies were carried out in the UK in an NHS Pain Clinic by the same research 
group. The other was carried out in the Netherlands in participants‟ own homes (n = 
14) or a physiotherapy practice (n = 1).  
All studies used individual semi-structured interviews with open questions to collect 
data. Two conducted repeat interviews. One study also conducted a focus group 
made up of healthcare professionals (n = 6) to discuss, optimise, and verify the 
theory constructed from the patient interviews. Interviews in all studies were audio-
recorded and transcribed verbatim. Data was analysed using a range of qualitative 
techniques including interpretive phenomenological analysis, grounded theory, and 
theoretical thematic analysis.  
Included studies provided data regarding the (i) experiences of participating in PNE 
for patients with CMP (ii) the extent, and nature of patients reconceptualisation of 
their CMP following PNE. (iii) experiences of patients with CMP who recently 
received PNE in a transdisciplinary setting.
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Deviations from original protocol  
In addition to the two primary outcome measures of pain and disability, there were 
several outcome measures, which under our protocol were classified as secondary 
outcome measures including; 12 validated psychosocial outcome measures; four 
physical performance outcome measures; and three objective outcome measures of 
pain pressure threshold. A summary can be seen in document SDC3.  
Jackson and Turner (2017)22 recommend only pooling data where there are no less 
than five studies to ensure that the power from a random-effects meta-analysis is 
greater than that of the individual studies. Thus, only pain, disability, pain 
catastrophising, and kinesiophobia met this criterion and could be pooled. The 
decision was made to only report results for those measures that met this criterion to 
keep the review focussed and coherent within the confines of a single article. Thus, 
pain, disability and pain catastrophising were pooled in the short (<3 months) and 
medium-term (≥3-6 months). Kinesiophobia was pooled in the short-term only. 
Where pooling was not appropriate for the included outcomes, it was presented 
narratively. 
 
Findings of the review 
Quantitative component 
Data was classified under three time points including short-term (<3 months), 
medium-term (≥3-6 months) and long-term (≥12 months)7. 
Primary outcome – Pain 
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Ten RCTs collected data on pain. A variety of outcome measures were used to 
collect pain data including 0-10 numerical rating scales (NRS) by four  
studies2,11,27,28,48 100mm visual analogue scales (VAS) by three studies35,41,60 the 
Medical Outcomes Short-Form 36 Health Status Survey (SF-36), for which the 
category „bodily pain‟ was used by one study58; the Fibromyalgia impact 
questionnaire, for which the 0-10 NRS was used by one study57; and The Western 
Ontario and McMaster Universities Osteoarthritis Index (WOMAC) by one study25.  
Three studies assessed pain using pain pressure thresholds25,31,58. However, it was 
inappropriate to pool this data with the questionnaires from other studies.  
Data was available for nine RCTs for which pain was assessed in the short-term, 
and seven in the medium-term. All pain outcomes were converted into a 100mm 
VAS to allow pooling, with a higher percentage indicating more pain6. 
Short-term 
The random effects pooled results across all PNE interventions vs control in nine 
studies2,11,27,28,35,41,48,57,58,60 (n = 524 participants) showed the mean pain reduction of 
PNE to be 3.20mm greater on the 100mm VAS (95% CI: -6.66 to 0.27) than control 
(P = 0.07): high quality evidence (Fig. 4 Forest). Heterogeneity was low (I = 3.79, 
tau =  1.07).  
 
 
Medium-term 
The random effects pooled results across all PNE interventions vs control in seven 
studies2,11,27,28,41,57,58,60 (n = 457 participants) showed mean pain reduction of PNE to 
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be 4.22mm greater on the 100mm VAS (95% CI: -16.44 to 8.01) than control (P = 
0.499): low quality evidence (Fig. 5 Forest). Heterogeneity was considerable (I = 
85.87, tau =  14.30).  
 
 
Long-term 
Only two studies reported on pain in the long term and thus were not pooled. Von 
Bertouch, McAuley and Moseley, (2011) compared PNE plus PMP vs Back book 
education plus PMP, with both groups showing decreases from baseline of 53mm 
and 22mm on 100mm VAS respectively.  
Louw (2014/16) compared PNE plus lumbar surgery vs lumbar surgery alone, with 
both groups showing decreases from baseline at 12 months for leg pain of 3.7 and 
3.3 points on 0-10 NRS for the PNE and control groups respectively (P > 0.075). At 
36 months, the groups showed reductions from baseline of 3.4 and 3.7 points for the 
PNE and control groups respectively (P = 0.028).  
 
Primary outcome – Disability 
 
Eleven RCTs collected data on disability. A variety of outcome measures were used 
including the Roland Morris Disability Questionnaire (RMDQ) by three studies2,35,48; 
the Oswestry Disability Index (ODI) by two studies27,28,48; the Patient Specific 
Functional Scale (PSFS) by three studies11,60; The Pain Disability Index by one 
study30; the Medical Outcomes Short-Form 36 Health Status Survey (SF-36), for 
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which the category „physical functioning‟ was used by one study58; the Fibromyalgia 
impact questionnaire, for which „physical functioning‟ was used by one study57; the 
Quebec Back Pain Disability Scale by one study41; the WOMAC by one study25. 
Disability data were available for 10 RCTs in the short term, and seven in the 
medium-term. All measures of disability were converted into a score /100 to facilitate 
pooling, with a higher score indicating greater disability. 
 
Short-term 
The random effects pooled results across all PNE interventions vs control in ten 
studies2,11,27,28,30,35,41,48,57,58,60 (n = 644 participants) showed mean disability reduction 
of PNE to be 4.10/100 (95% CI: -7.89 to -0.32) greater than control (P = 0.03): 
moderate quality evidence (Fig. 6 Forest). Heterogeneity was considerable (I = 
86.17, tau =  4.65). Téllez-García et al. (2015)48 collected two disability outcome 
measures (RMDQ and ODI). Following discussion, we chose to use the ODI within 
the analysis and undertook a sensitivity analysis replacing the ODI with the RMDQ. 
This had no statistically or clinically significant effect on the results.  
 
 
Medium-term 
The random effects pooled results across all PNE interventions vs control in seven 
studies2,11,27,28,41,57,58,60 (n = 457 participants) showed mean disability reduction of 
PNE to be 8.23/100 (95% CI: -15.61 to -0.84) greater than control (P = 0.03): 
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moderate quality evidence (Fig. 7 Forest). Heterogeneity was considerable (I = 
95.53, tau =  9.25).  
 
Long-term 
Only two studies reported on disability in the long term and thus were not pooled. 
Von Bertouch, McAuley and Moseley, (2011)60 compared PNE plus a PMP vs Back 
book education plus a PMP, with both groups showing decreases from baseline of 
6.3 and 5.1 points /10 on the PSFS respectively. Louw et al.27,28 compared PNE plus 
lumbar surgery vs lumbar surgery alone, with both groups showing decreases for 
disability of 19 and 23 points on 0-100 ODI respectively at 12 months follow up. The 
effect of group did not reach statistical significance (P > 0.075). At 36 months, the 
groups showed reductions of 21 and 22 points, respectively. The effect of group did 
not reach statistical significance (P = 0.317). There were no significant differences 
between year 1 and 3 (P = 0.761). 
 
Secondary outcome – Pain Catastrophising  
 
Ten RCTs collected data on pain catastrophising2,11,25,27,28,31,30,35,57,58,60. All studies 
used the Pain Catastrophising Scale (PCS). PCS datum for one study was not 
available and could not be provided by the author on request60. 
 
Short-term 
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The random effects pooled results across all PNE interventions vs control in nine 
studies2,11,25,27,28,30,31,35,57,58 (n = 598 participants) showed mean pain catastrophising 
reduction of PNE to be 3.33 points /52 on the PCS (95% CI: -6.01 to -0.65) greater 
than control (P = 0.02): moderate quality evidence (Fig. 8 Forest). Heterogeneity was 
considerable (I = 97.62, tau =  3.79).  
 
 
Medium-term 
The random effects pooled results across all PNE interventions vs control in six 
studies2,11,25,27,28,57,58 (n = 375 participants) showed mean pain catastrophising 
reduction of PNE to be 5.26 points /52 on the PCS (95% CI: -10.59 to 0.08) greater 
than control (P = 0.053): moderate quality evidence (Fig. 9 Forest). Heterogeneity 
was considerable (I = 99.03, tau =  6.35).  
 
 
Long-term 
Only one study reported on pain catastrophising in the long term27,28 comparing PNE 
plus lumbar surgery vs lumbar surgery alone, with both groups showing decreases 
for pain catastrophising of 12.3 and 13.3 points on 0-52 PCS respectively at 12 
months follow up. The statistical significance of this is unknown. At 36 months, the 
groups showed reductions of 15.0 and 19.3 points respectively. The statistical 
significance of this is unknown. 
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Secondary outcome – Kinesiophobia  
Seven RCTs collected data on Kinesiophobia2,25,30,31,41,48,58. All studies used the 
Tampa Scale for Kinesiophobia (TSK), with three studies using the 17-item version 
(TSK-17)30,48,58; one study using the 17-item chronic fatigue syndrome version (TSK-
CFS)31; one study using the 13-item version (TSK-13)41; and two studies using the 
11-item version (TSK-11)2,25. TSK data was converted into a percentage to allow 
pooling, with a higher percentage indicating greater kinesiophobia. 
 
Short-term  
The random effects pooled results across all PNE interventions vs control in seven 
studies2,20,30,31,41,48,58 (n = 372 participants) showed mean reduction in kinesiophobia 
of PNE to be 13.55% on the TSK (95% CI: -25.89 to -1.21) greater than control (P = 
0.03): moderate quality evidence (Fig. 10 Forest). Heterogeneity was considerable 
(I = 97.25, tau =  16.19).  
 
 
Medium-term 
Four studies investigated kinesiophobia. Van Oosterwijck et al. (2013)58 compared 
PNE vs Self-management advice, with both groups showing decreases from 
baseline at 3 months of 3 and 1 points respectively on 17-68 TSK-CFS. The exact P 
value was not provided however the authors did report it was not statistically 
significant. Pires et al. (2015)41 compared PNE plus aquatic therapy to aquatic 
therapy alone, with both groups showing decreases from baseline at 3 months of 5 
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and 3 points respectively on 13-52 TSK-13. This was not statistically significant. 
Lluch et al. (2018)25 compared PNE plus knee joint mobilisations and total knee 
replacement to biomedical education plus knee joint mobilisations and total knee 
replacement with both groups showing reductions from baseline at 5 months of 13 
and 3 points on the 11-44 TSK-11. This reached statistical significance (P < 0.01) in 
favour of PNE. Bodes et al. (2018)2 compared PNE plus therapeutic exercise to 
therapeutic exercise alone with both groups showing reductions from baseline at 3 
months of 13 and 4 points on 11-44 TSK-11. This reached statistical significance in 
favour of PNE; P = <.01.  
 
Long-term 
No studies looked at kinesiophobia in the long term. 
Possible sources of heterogeneity (Publication bias, study quality, age, %male, 
baseline pain, duration of pain, PNE alone or PNE + intervention and duration of 
education) were explored using meta-regression analyses (See document SDC4). 
For pain in the short-term all covariates were not significant (P > 0.05) except for 
PNE alone or PNE + intervention (P = 0.01), coefficient = -8.9074. For pain in the 
medium-term all covariates were not significant (P > 0.05). 
For disability in the short-term all covariates were not significant (P > 0.05). For 
disability in the medium-term all covariates were not significant (P > 0.05) except for 
PNE alone or PNE + intervention (P < 0.01), coefficient = -15.2197 and duration of 
education (P = 0.03), coefficient = -7.0841. 
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For PCS in the short-term all covariates were not significant (P > 0.05) except for 
PNE alone or PNE + intervention (P < 0.01), coefficient = -7.6528. For PCS in the 
medium-term all covariates were not significant (P > 0.05) except for PNE alone or 
PNE + intervention (P < 0.01), coefficient = -9.7706 and duration of education (P < 
0.01), coefficient = -6.8079. 
For TSK in the short-term all covariates were not significant (P > 0.05) except for 
baseline pain (P < 0.01), coefficient = -0.8468. 
 
Qualitative component 
Two synthesised findings were generated from 23 study findings extracted from four 
studies (See document SDC5). Findings were illustrated using direct participant 
quotes and authors‟ descriptions, therefore they were assigned a mix of unequivocal 
and credible levels of credibility. Findings were grouped according to similarity of 
concept into five categories (See document SDC6), and two synthesised findings:  
 
Synthesised finding 1: A comprehensive assessment allowing the patient to tell 
their own story should be undertaken to ensure they feel heard. This will also 
facilitate the identification of their prior understanding and beliefs. PNE can then be 
delivered in a manner relevant to that patient. In addition, patients clarifying their 
story to a healthcare professional may raise their awareness of the biopsychosocial 
nature of pain, promoting readiness to engage with PNE. (See SDC7). 
Synthesised finding 2: Achieving pain reconceptualisation can enhance patients‟ 
ability to cope with their condition. To promote pain reconceptualisation PNE should 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
 25 
be delivered by health care professionals (HCPs) skilled in PNE delivery and 
facilitation of group, or one-to-one interactions with, and between, patients and other 
HCPs. Progress towards reconceptualisation should be monitored throughout, 
tailoring concepts that have not been accommodated to ensure relevance of PNE to 
the individual. (See SDC8). 
 
Discussion 
This mixed methods review aimed to undertake a segregated synthesis of 
quantitative and qualitative studies to investigate the clinical effectiveness, and 
patients‟ experience of, PNE for people with CMP. Data from 12 RCTs (n = 755 
participants) demonstrated that PNE can reduce pain, disability, pain catastrophising 
and kinesiophobia in the short-to-medium-term. Data from four qualitative studies (n 
= 50 participants) identified several key components important for enhancing the 
patient experience of PNE such as allowing the patient to tell their own story. These 
components can enhance pain reconceptualisation, which appears to be an 
important process to facilitate patients‟ ability to cope with their condition. 
An improvement in clinical outcomes of 10% has been proposed as a minimally 
clinically important difference (MCID) in the recent NICE guidelines for back and 
radicular pain37. Pooled data showed a reduction in pain and disability in favour of 
PNE ranging from 3-8/100units, which are likely of little clinical benefit. In contrast, 
pooled data showed a reduction in pain catastrophising in favour of PNE of 5.26 
units (CI: -10.59 to 0.08) in the medium-term (A change of 5.2 units (10%) is 
considered clinically meaningful) and a reduction in Kinesiophobia of 13.55/100 units 
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(CI: -25.89 to -1.21) in the short-term. Thus, in the short-to-medium-term clinically 
meaningful improvements were seen in these psychosocial outcome measures.  
Previous narrative reviews have concluded that there is „compelling‟ and „strong‟ 
evidence that PNE positively effects pain and disability26,29, which contrasts with our 
findings likely due to the differences in methodological approach and the inclusion of 
a number of additional studies not published at the time of those previous 
reviews2,25,30. Moseley and Butler (2015)33 were more reserved in the conclusions of 
their narrative review stating that alone PNE is not a viable intervention for improving 
pain and disability. This is broadly in keeping with our findings.  
Our findings for short-term pain relief (-3.20/100mm) are similar in magnitude to the 
effect reported by Clarke et al. (2011)7 (-5/100mm) and Wood and Hendrick, (2018)63 
(-0.73/10). In contrast Tegner et al. (2018)47 reported an improvement above the 
MCID (-1.03/10) more in keeping with previous narrative reviews26,29. Our findings for 
pain relief in the medium-term (-4.22/100mm) also differ from Tegner et al. (2018)47 
who found a clinically relevant effect (-1.09/10).  
Our findings for short-term disability (-4.10/100units) show smaller effects compared 
to Wood and Hendrick, (2018)63 (-2.28/24) and Tegner et al. (2018)47 (-1/10). In 
contrast our findings for medium-term disability (-8.23/100units) are similar in 
magnitude to Tegner et al. 2018 (-0.82/10)47. 
Previous narrative reviews have reported favourable findings for PNE reducing pain 
catastrophising7,26,29. Our findings in part support this previous work finding PNE to 
produce a clinically meaningful improvement in pain catastrophising in the medium-
term, though not the short-term. It may be that in the case of certain psychosocial 
measures there is a time lag in the effect. We can only hypothesise as to why this 
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lag may occur though it may be that a period of reflection and experimentation with 
the knowledge gained from PNE is needed to facilitate pain reconceptualisation 
and/or clinical improvements.  
For kinesiophobia previous narrative reviews have reported inconclusive findings 
with mixed results26,29 and no clear conclusions made. This differs to our work where 
we found PNE to have a greater effect on kinesiophobia than any other measure 
investigated in the short-term (-13.55%). This is likely due to the inclusion of three 
recently published studies2,25,30, two of which found PNE to have a particularly large 
beneficial effect for kinesiophobia. Our findings for kinesiophobia in the short-term 
are greater than that of Tegner et al. (2018)47 (-5.73/68) and Wood and Hendrick 
(2018)63 (-4.72/52). 
The current work builds on the three previous meta-analysis on PNE7,47,63. Firstly, we 
registered a protocol prior to commencing the review. Secondly, this is the first meta-
analysis where the pooled data included the minimum five recommended studies to 
ensure sufficient statistical power22. Thirdly, the current work could isolate the effect 
of PNE through the inclusion of studies that compared (i) PNE to true control (or 
usual care), (ii) concomitant studies, where PNE has been delivered in addition to 
another intervention where that other intervention has been received by both groups, 
(iii) head-to-head studies where PNE has been compared to another active 
intervention. Finally, the current review meta-analysed data from studies‟ whose 
samples included heterogeneous CMP. This is the first meta-analysis to be 
performed on this sample in PNE. The second, third and final points may also go 
some way in explaining the differences in pooled effects found between the current 
and past reviews7,47,63.  
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With the exception of pain in the short-term, there was substantial heterogeneity 
between studies. To explore this heterogeneity a series of meta-regressions were 
undertaken. Greater effects for pain (short-term), disability (medium-term) and pain 
catastrophising (short and medium-term) were seen when PNE was combined with 
another intervention compared to PNE delivered in isolation. Similarly, greater 
effects for disability (medium-term) and pain catastrophising (medium-term) were 
seen when longer durations of PNE were delivered. However, the slopes of the 
meta-regressions were shallow indicating that the unit improvements in these 
outcomes for combined interventions (and longer duration interventions) are small 
and of questionable clinical relevance. Our findings are in keeping with Wood and 
Hendrick (2018)63 and a recent doctoral thesis meta-analysis reporting PNE 
combined with another therapy to be more effective than PNE alone for pain and 
disability in individuals with CLBP63,64. This finding is also in agreement with two 
previous narrative reviews29,33. However, the combination of PNE with other 
interventions should be done in a co-ordinated way to ensure that patients do not get 
mixed-messages potentially reducing the effectiveness of PNE43. 
The two synthesised findings were split into principles to facilitate the mixed-methods 
analysis. See Table 7.  
It was difficult to discern if the principles identified within the qualitative work were 
used by the included individual RCTs given the information provided. Only two 
principals were identified across the RCTs (S2a and S2c).  
Principal S2a was identified in 6 RCTs where the skill of the PNE deliverer was 
described using terms such as „experienced‟2,25,35, „with clinical experience‟30, and 
„specially trained‟58,60. Whilst we interpreted these terms all to mean skilled in PNE 
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delivery, we accept that it is possible that a HCP could be „specially trained‟, 
„experienced‟ or have „clinical experience‟ and still not be „skilled‟ in the delivery of 
PNE.  
Four RCTs monitored pain reconceptualisation throughout PNE, tailoring concepts 
not understood to the individual (principal S2c). Pain reconceptualisation was 
monitored via participant questions in two RCTs30,48 whilst the two other RCTs used 
questionnaires25,58. 
The qualitative synthesis suggests that PNE is helpful for coping with CMP when 
pain reconceptualisation is achieved (S2d). Our meta-analysis found PNE to produce 
clinically significant reductions in kinesiophobia (short-term) and pain catastrophising 
(medium-term). Whilst not a direct measure of pain reconceptualisation, they do 
provide an insight into how an individual understands their pain, and how threatened 
they feel because of it. We can infer that one of the ways PNE is helpful for coping is 
by reducing the threat value of pain. This less threatening and fearful state of being 
(reduced fear of movement and reduced catastrophic thinking) may change a 
patients‟ priority away from pain control towards pursuit of valued life goals, breaking 
the cycle of fear-avoidance-interference-negative affect-pain illustrated by the fear-
avoidance model of pain59. Furthermore, the patient may be more open to active 
interventions such as exercise, where previously this would have been avoided due 
to fear of pain, thus promoting recovery. 
PNE usually includes pacing and graded exposure, such as the twin peaks model in 
the Explain Pain manual4. Importantly, this goes some way in showing the patient 
how to engage in their valued life goals/exercise whilst avoiding the Boom-Bust 
cycle. It is likely that working out how to engage in valued life goals/exercise will be 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
 30 
challenging for patients, and thus may take time before progress is made in this 
domain. This is in part reflected in the quantitative component of this review where 
disability approached clinical significance in the medium-term, but not the short-term. 
As patients begin to master the skills of pacing and graded exposure, their 
engagement in valued life goals/exercise may increase, with associated decreases 
in disability. 
Strengths and Limitations 
One limitation of this review was that it did not look at economic outcomes such as 
cost effectiveness. A recent RCT on acute low back pain (and thus not eligible for 
this review) by Traeger et al. (2018)54 found PNE to reduce health care utilisation at 
3 months (but not 12 months) over control. Louw et al.27,28 and Moseley (2002)32 
found PNE to reduce healthcare usage within a CMP sample and therefore may be a 
cost-effective intervention, an important consideration given the large financial 
burden associated with CMP.  
The heterogeneity of design, participants, outcome measures, delivery methods and 
comparators could be considered a limitation of this review. Some may question the 
validity of pooling such data. However, by reporting I2 and Tau we have been 
transparent about the statistical heterogeneity and we have explored the 
heterogeneity using meta-regression.  
Another limitation was that only studies published in English were eligible for 
inclusion as no facility for translation was available. Thus, important data from non-
English studies may have been missed. 
Lack of response and/or inadequate reporting in the original studies resulted in the 
SD of change being estimated for four RCTs reporting on pain and disability, five 
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studies reporting on pain catastrophising and three studies reporting on 
kinesiophobia. While this is accepted Cochrane review practice it is still an 
estimation. 
There was a paucity of qualitative studies with three of those coming from our group. 
The studies from our group were assessed for quality by members of the review 
team who were not authors on those original qualitative studies to minimise bias.  
 
Conclusions and implications of this review 
Implications for policy and practice  
The qualitative component of this review identified several important components for 
optimising the patient experience such as the need for a skilled clinician to deliver 
the intervention with expertise in group facilitation and/or one-to-one interactions. 
These have implications not just for how PNE should be delivered but also for the 
training of the education provider. The quantitative findings also provide useful 
direction for how PNE should be delivered to enhance effectiveness such as 
delivering longer total durations of PNE and combining PNE with other interventions.  
Implications for research 
Given the apparent additional effects of longer durations of PNE and delivering PNE 
in combination with other interventions, future research should explore the dosage 
response to PNE and combinations with other interventions to provide guidance on 
the development of optimal interventions. In addition, the qualitative component of 
this review has identified a number of components which optimise the patient 
experience. Quantitative studies are needed to explore what influence optimising 
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these components have on patient outcomes. More studies investigating cost-
effectiveness are needed. There is a need for more RCTs to investigate the long-
term effectiveness of PNE. There is a need for more qualitative research into PNE 
from a wider number of research groups to explore and enhance the transferability of 
our qualitative findings. 
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Figure 1: PRISMA flow diagram of search and study selection process 
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Figure 2: Risk of bias graph: review authors' judgements about each risk of bias item 
presented as percentages across all included studies. 
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Figure 3: Risk of bias summary: review authors' judgements about each risk of bias 
item for each included study. 
 
 
 
Figure 4: Forest plot of PNE versus control in short-term; primary outcome pain. The 
95% prediction interval for the mean effect was -7.95 to 1.56.  
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Figure 5: Forest plot of PNE versus control in medium-term; primary outcome pain. 
The 95% prediction interval for the mean effect was -42.38 to 33.95.  
 
 
 
 
Figure 6: Forest plot of PNE versus control in short-term; primary outcome disability. 
The 95% prediction interval for the mean effect was -15.42 to 7.25.  
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Figure 7: Forest plot of PNE versus control in medium-term; primary outcome 
disability. The 95% prediction interval for the mean effect was -32.62 to 16.34.  
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Figure 8: Forest plot of PNE versus control in short-term; secondary outcome pain 
catastrophising. The 95% prediction interval for the mean effect was -12.61 to 5.96.  
 
 
 
 
Figure 9: Forest plot of PNE versus control in medium-term; secondary outcome pain 
catastrophising. The 95% prediction interval for the mean effect was -23.01 to 12.49.  
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Figure 10: Forest plot of PNE versus control in short-term; secondary outcome 
kinesiophobia. The 95% prediction interval for the mean effect was -56.06 to 28.96.  
 
Tables: 
 
Table 1 Summary of findings 
PNE compared to control for treatment of adults with chronic musculoskeletal pain 
Patient or population: treatment of adults with chronic musculoskeletal pain  
Setting:  
Intervention: PNE  
Comparison: control  
Outcomes Anticipated absolute effects
*
 
(95% CI)  
Relative 
effect 
(95% CI)  
№ of 
participants  
(studies)  
Certainty of 
the 
evidence 
(GRADE)  
Comments 
Risk with 
control 
Risk with PNE 
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Table 1 Summary of findings 
PNE compared to control for treatment of adults with chronic musculoskeletal pain 
Patient or population: treatment of adults with chronic musculoskeletal pain  
Setting:  
Intervention: PNE  
Comparison: control  
Outcomes Anticipated absolute effects
*
 
(95% CI)  
Relative 
effect 
(95% CI)  
№ of 
participants  
(studies)  
Certainty of 
the 
evidence 
(GRADE)  
Comments 
Risk with 
control 
Risk with PNE 
Pain score in 
the short term 
(ST Pain) 
assessed with: 
100mm VAS 
Scale from: 0 
to 100 (Higher 
is worse)  
The mean 
change in pain 
score in the 
short term was 
-15 mm  
The mean 
change in pain 
score in the 
short term in 
the 
intervention 
group was 
3mm lower (7 
lower to 0 
higher) than 
the control 
group 
-  524 
(9 RCTs)  
⨁⨁⨁⨁ 
HIGH 
a,b,c,d,e,f,g,h
 
Lower score indicates lower 
pain. A change of less than 
10mm is considered not 
clinically important. PNE 
does not reduce pain score 
in the short term. 
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Table 1 Summary of findings 
PNE compared to control for treatment of adults with chronic musculoskeletal pain 
Patient or population: treatment of adults with chronic musculoskeletal pain  
Setting:  
Intervention: PNE  
Comparison: control  
Outcomes Anticipated absolute effects
*
 
(95% CI)  
Relative 
effect 
(95% CI)  
№ of 
participants  
(studies)  
Certainty of 
the 
evidence 
(GRADE)  
Comments 
Risk with 
control 
Risk with PNE 
Pain score in 
the medium 
term (MT Pain) 
assessed with: 
100mm VAS 
Scale from: 0 
to 100 (Higher 
is worse) 
follow up: 
range 3 
months to 6 
months  
The mean 
change in pain 
score in the 
medium term 
was -18 mm  
The mean 
change in pain 
score in the 
medium term 
in the 
intervention 
group was 4 
mm lower (16 
lower to 8 
higher) than 
the control 
group 
-  457 
(7 RCTs)  
⨁⨁◯◯ 
LOW 
a,g,h,i,j,k,l,m
 
Lower score indicates lower 
pain. A change of less than 
10mm is considered not 
clinically important. PNE 
may result in little to no 
difference in pain score in 
the medium term. 
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Table 1 Summary of findings 
PNE compared to control for treatment of adults with chronic musculoskeletal pain 
Patient or population: treatment of adults with chronic musculoskeletal pain  
Setting:  
Intervention: PNE  
Comparison: control  
Outcomes Anticipated absolute effects
*
 
(95% CI)  
Relative 
effect 
(95% CI)  
№ of 
participants  
(studies)  
Certainty of 
the 
evidence 
(GRADE)  
Comments 
Risk with 
control 
Risk with PNE 
Change in 
disability score 
in the short 
term (ST 
Disability) 
assessed with: 
Validated 
measure of 
disability 
converted to 
percentage 
Scale from: 0 
to 100 (Higher 
is worse)  
The mean 
change in 
disability score 
in the short 
term was -13 
units  
The mean 
change in 
disability score 
in the short 
term in the 
intervention 
group was 4 
units lower (8 
lower to 0 
lower) than the 
control group 
-  644 
(10 RCTs)  
⨁⨁⨁◯ 
MODERATE 
a,b,c,g,h,k,l,m
 
Lower score indicates lower 
disability. A change of less 
than 10 units is considered 
not clinically important. PNE 
probably results in a small 
possibly unimportant effect 
in disability score in the 
short term. 
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Table 1 Summary of findings 
PNE compared to control for treatment of adults with chronic musculoskeletal pain 
Patient or population: treatment of adults with chronic musculoskeletal pain  
Setting:  
Intervention: PNE  
Comparison: control  
Outcomes Anticipated absolute effects
*
 
(95% CI)  
Relative 
effect 
(95% CI)  
№ of 
participants  
(studies)  
Certainty of 
the 
evidence 
(GRADE)  
Comments 
Risk with 
control 
Risk with PNE 
Change in 
disability score 
in the medium 
term (MT 
Disability) 
assessed with: 
Validated 
measure of 
disability 
converted to 
percentage 
Scale from: 0 
to 100 (Higher 
is worse) 
follow up: 
range 3 
months to 6 
months  
The mean 
change in 
disability score 
in the medium 
term was -13 
units  
The mean 
change in 
disability score 
in the medium 
term in the 
intervention 
group was 8 
units lower (16 
lower to 1 
lower) than the 
control group 
-  457 
(7 RCTs)  
⨁⨁⨁◯ 
MODERATE 
a,b,g,h,j,k,l,m
 
Lower score indicates lower 
disability. A change of less 
than 10 units is considered 
not clinically important. PNE 
probably results in a small 
possibly unimportant effect 
in disability score in the 
medium term. 
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Table 1 Summary of findings 
PNE compared to control for treatment of adults with chronic musculoskeletal pain 
Patient or population: treatment of adults with chronic musculoskeletal pain  
Setting:  
Intervention: PNE  
Comparison: control  
Outcomes Anticipated absolute effects
*
 
(95% CI)  
Relative 
effect 
(95% CI)  
№ of 
participants  
(studies)  
Certainty of 
the 
evidence 
(GRADE)  
Comments 
Risk with 
control 
Risk with PNE 
Change in pain 
catastrophising 
score in the 
short term (ST 
PCS) 
assessed with: 
Pain 
catastrophising 
scale 
Scale from: 0 
to 52 (Higher 
is worse)  
The mean 
change in pain 
catastrophising 
score in the 
short term was 
-2.8 units  
The mean 
change in pain 
catastrophising 
score in the 
short term in 
the 
intervention 
group was 3.3 
units lower (6 
lower to 0.6 
lower) than the 
control group 
-  598 
(9 RCTs)  
⨁⨁⨁◯ 
MODERATE 
a,b,g,h,j,k,l,m
 
Lower score indicates lower 
pain catastrophising. A 
change of less than 5.2 units 
is considered not clinically 
important. PNE probably 
results in a small possibly 
unimportant effect in pain 
catastrophising score in the 
short term. 
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Table 1 Summary of findings 
PNE compared to control for treatment of adults with chronic musculoskeletal pain 
Patient or population: treatment of adults with chronic musculoskeletal pain  
Setting:  
Intervention: PNE  
Comparison: control  
Outcomes Anticipated absolute effects
*
 
(95% CI)  
Relative 
effect 
(95% CI)  
№ of 
participants  
(studies)  
Certainty of 
the 
evidence 
(GRADE)  
Comments 
Risk with 
control 
Risk with PNE 
Change in pain 
catastrophising 
score in the 
medium term 
(MT PCS) 
assessed with: 
Pain 
catastrophising 
scale 
Scale from: 0 
to 52 (worse) 
follow up: 
range 3 
months to 6 
months  
The mean 
change in pain 
catastrophising 
score in the 
medium term 
was -4.4 units  
The mean 
change in pain 
catastrophising 
score in the 
medium term 
in the 
intervention 
group was 5.3 
units lower 
(10.6 lower to 
0.1 higher)  
-  375 
(6 RCTs)  
⨁⨁⨁◯ 
MODERATE 
a,b,g,h,j,k,l,m
 
Lower score indicates lower 
pain catastrophising. A 
change of less than 5.2 units 
is considered not clinically 
important. PNE probably 
reduces pain catastrophising 
score in the medium term 
slightly.  
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Table 1 Summary of findings 
PNE compared to control for treatment of adults with chronic musculoskeletal pain 
Patient or population: treatment of adults with chronic musculoskeletal pain  
Setting:  
Intervention: PNE  
Comparison: control  
Outcomes Anticipated absolute effects
*
 
(95% CI)  
Relative 
effect 
(95% CI)  
№ of 
participants  
(studies)  
Certainty of 
the 
evidence 
(GRADE)  
Comments 
Risk with 
control 
Risk with PNE 
Change in 
kinesiophobia 
score in the 
short term (ST 
TSK) 
assessed with: 
Tampa Scale 
for 
Kinesiophobia 
converted to 
percentage 
Scale from: 0 
to 100 (worse)  
The mean 
change in 
kinesiophobia 
score in the 
short term was 
-4 units  
The mean 
change in 
kinesiophobia 
score in the 
short term in 
the 
intervention 
group was 14 
units lower (26 
lower to 1 
lower)  
-  372 
(7 RCTs)  
⨁⨁⨁◯ 
MODERATE 
a,g,h,j,k,l,m,n
 
Lower score indicates lower 
kinesiophobia. A change of 
less than 10 units is 
considered not clinically 
important. PNE probably 
reduces kinesiophobia score 
in the short term slightly.  
*The risk in the intervention group (and its 95% confidence interval) is based on the assumed risk in the comparison group 
and the relative effect of the intervention (and its 95% CI).  
 
CI: Confidence interval  
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Table 1 Summary of findings 
PNE compared to control for treatment of adults with chronic musculoskeletal pain 
Patient or population: treatment of adults with chronic musculoskeletal pain  
Setting:  
Intervention: PNE  
Comparison: control  
Outcomes Anticipated absolute effects
*
 
(95% CI)  
Relative 
effect 
(95% CI)  
№ of 
participants  
(studies)  
Certainty of 
the 
evidence 
(GRADE)  
Comments 
Risk with 
control 
Risk with PNE 
GRADE Working Group grades of evidence 
High certainty: We are very confident that the true effect lies close to that of the estimate of the effect 
Moderate certainty: We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of 
the effect, but there is a possibility that it is substantially different 
Low certainty: Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate 
of the effect 
Very low certainty: We have very little confidence in the effect estimate: The true effect is likely to be substantially different 
from the estimate of effect  
Explanations 
a. The majority of the weight comes from low risk studies. Although there was some concern over blinding of participants and 
personnel, this predominantly came from lack of blinding of personnel, which is normal for such studies.  
b. Some variation is size of the effect, however mostly in the same direction.  
c. Good overlap of the confidence intervals.  
d. Not signifiant P value.  
e. I-Squared below 50%  
f. Tau-Squared lower than point estimate  
g. Sample of chronic musculoskeletal pain comparing PNE against control using an appropriate outcome measure.  
h. Sample size above 300. Below the criterion (10%) for appreciable harm.  
i. Large variation in size of the effect, going in both directions.  
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j. Poor overlap between the confidence intervals.  
k. Significant P value.  
l. I-Squated above 50%  
m. Tau-Squared higher than point estimate.  
n. Some variation in the size of the effect, all going in the same direction.  
 
Table 2 ConQual summary of findings  
Systematic Review title: Pain neuroscience education for adults with chronic musculoskeletal pain: a 
mixed-methods systematic review 
Population: adults with chronic musculoskeletal pain 
Phenomena of interest: the perceptions of PNE in adults with chronic musculoskeletal pain including 
1) their experiences of participating in PNE 2) their perceptions of its effectiveness 3) explore how it 
influenced their understanding of pain. 
Synthesised finding Type of 
research 
Dependability Credibility ConQual 
score 
A comprehensive assessment allowing the 
patient to tell their own story should be 
undertaken to ensure they feel heard. This 
will also facilitate the identification of their 
prior understanding and beliefs. PNE can 
then be delivered in a manner relevant to 
that patient. In addition, patients clarifying 
their story to a healthcare professional may 
raise their awareness of the 
biopsychosocial nature of pain, promoting 
readiness to engage with PNE. 
Qualitative Downgrade 1 
level* 
Downgrade 
1 level** 
Low 
Achieving pain reconceptualisation can 
enhance patients‟ ability to cope with their 
condition. To promote pain 
reconceptualisation PNE should be 
delivered by health care professionals 
(HCPs) skilled in PNE delivery and 
Qualitative Downgrade 1 
level* 
Downgrade 
1 level** 
Low 
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facilitation of group, or one-to-one 
interactions with, and between, patients 
and other HCPs. Progress towards 
reconceptualisation should be monitored 
throughout, tailoring concepts that have not 
been accommodated to ensure relevance 
of PNE to the individual. 
*Downgraded one level as whilst two studies scored perfectly on dependability, the other two studies scored 3 and 1. The mean 
dependability score was 3.5. 
** Downgraded one level due to a mix of unequivocal and equivocal findings. 
 
Table 3 Critical appraisal of quantitative studies 
Study Score /7 Score /7 as a 
Percentage 
Bodes 20182 4 57% 
Gallager 201311 5 71% 
Lluch 201825 5 71% 
Louw 2014/1627,28 3 43% 
Malfliet 201830 6 86% 
Meeus 201031 5 71% 
Moseley 200435 5 71% 
Pires 201541 3 43% 
Téllez-Garcia 201548 2 29% 
van Ittersum 201357 1 14% 
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Van Oosterwijck 201358 5 71% 
Von Bertouch 201160 5 71% 
 
Table 4 Critical appraisal of qualitative studies 
Citation Q1 Q2 Q3 Q4 Q5 Q6 Q7 Q8 Q9 Q10 Total 
Robinson et al. 
2016
42
 
U Y Y Y Y Y Y Y Y Y 9 
King et al. 2016
24
 U Y Y Y Y Y Y Y Y Y 9 
Wijma et al. 2017
61
 U Y Y Y Y N N Y U Y 6 
King et al. 2018
23
 N U U U U Y N Y Y Y 4 
% 0% 75% 75% 75% 75% 75% 50% 100% 75% 100%  
Y = yes; N = No; U = Unclear 
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Table 5 Characteristics of included studies - quantitative component 
 
Study Met
hod
s 
Sam
ple 
size 
(bas
eline
)/ 
gend
er/ 
mea
n 
age 
in 
year
s 
Particip
ants  
Interventio
n(s) 
Durati
on of 
educ
ation
al 
interv
entio
n 
Control Authors 
conclusi
ons/note
s 
Settin
g/ 
countr
y  
Mosel
ey, 
Nicho
las 
and 
Hodg
es 
RC
T 
N = 
58 
43% 
M 
43.5 
LBP of 
>6 
months 
duratio
n. 
Baselin
e pain 
3h 
individual 
PNE, with 
20m 
break.  10 
section 
workbook 
PNE 
2.67h 
 
Contr
ol 
2.67h 
3h 
individual 
Back 
education, 
with 20m 
break. 10 
section 
PNE 
results in 
some 
normalis
ation of 
pain 
cognition
Privat
e 
rehabi
litation 
clinics 
Unkno
wn 
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20043
5 
as 
mean 
% = 
59.5% 
Duratio
n of 
pain in 
mean 
(SD) 
months 
= 29.5 
(12) 
with 3 
questions 
at end of 
each 
section. To 
be 
completed 
over 10 
days. 
 
workbook 
with 3 
questions 
at end of 
each 
section. To 
be 
completed 
over 10 
days. 
 
s and 
physical 
performa
nce but 
not self-
perceive
d 
disability.  
Doubts 
raised 
about 
suitability 
of 
structural
-
patholog
y based 
educatio
n. 
Von 
Berto
uch 
20116
0  
RC
T 
N = 
64 
33% 
M 
42.4 
All 
chronic 
pain 
patient
s >50% 
2x 1.5h 
Group 
PNE + 
PMP. 
Manual to 
PNE 
3h 
 
Contr
ol 3h 
2x 1.5h 
Group 
Back book 
+ PMP. 
Manual to 
n/a Unkno
wn 
Unkno
wn 
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CLBP 
 
Baselin
e pain 
as 
mean 
% = 
64% 
Duratio
n of 
pain in 
mean 
months 
= 
unkno
wn 
be 
completed 
during 
PMP. 
Facilitated 
discussion 
about PNE 
at end of 
each week 
of PMP. 
 
be 
completed 
during 
PMP. 
Facilitated 
discussion 
about PNE 
at end of 
each week 
of PMP. 
 
Meeu
s et 
al. 
20103
1 
RC
T 
N = 
48 
17% 
M 
40.3 
Chroni
c 
fatigue 
syndro
me 
diagno
sed 
accordi
0.5h 
individual 
PNE 
 
PNE 
0.5h 
 
Contr
ol 
0.5h 
0.5h 
individual 
pacing and 
self-
managem
ent 
education 
PNE led 
to 
improved 
scores 
on the 
Neuroph
ysiology 
of Pain 
Chroni
c 
fatigu
e 
clinic. 
Bruss
els 
Belgiu
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ng to 
the 
1994 
Center
s for 
Diseas
e 
Control 
and 
Preven
tion 
criteria 
for 
CFS10. 
Patient
s also 
had 
chronic 
widesp
read 
pain 
diagno
sed 
accordi
 Test. 
PNE had 
immediat
e effects 
on 
ruminatin
g about 
pain. No 
therapy 
effect for 
pain 
threshold
s found. 
m.  
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ng to 
The 
Americ
an 
Colleg
e of 
Rheum
atology 
1990 
criteria
62. 
 
 
Baselin
e pain 
as 
mean 
% = 
Unkno
wn 
Duratio
n of 
pain in 
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mean 
months 
= 
unkno
wn 
van 
Itters
um et 
al. 
20135
7 
RC
T 
N = 
105 
7% 
M 
46.7 
Fibrom
yalgia 
diagno
sed 
accordi
ng to 
The 
Americ
an 
Colleg
e of 
Rheum
atology 
1990 
criteria
62. 
 
18-65 
years 
Written 
PNE + 1 
phone call 
for 
motivation/
questions 
+/- 2x 
phone 
calls/email
s for 
further 
clarificatio
n/question
s 
 
Unkn
own 
Written 
Relaxation 
exercises 
+ 1 phone 
call for 
motivation/
questions 
+/- 2x 
phone 
calls/email
s for 
further 
clarificatio
n/question
s 
 
Written 
PNE 
alone is 
not 
effective 
for 
changing 
the 
impact of 
the 
illness 
on daily 
life, pain 
catastrop
hising, or 
illness 
perceptio
ns in 
fibromyal
Speci
alised 
centre
s for 
chroni
c pain 
and 
chroni
c 
fatigu
e. 
Belgiu
m.  
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of age. 
 
Baselin
e pain 
as 
mean 
% = 
71.5% 
Duratio
n of 
pain in 
mean 
months 
= 
unkno
wn 
gia 
patients.  
Van 
Ooste
rwijck 
et al. 
20135
8 
RC
T 
N = 
30 
13% 
M 
45.9 
Fibrom
yalgia 
diagno
sed 
accordi
ng to 
The 
Americ
0.5h 
individual 
PNE. PNE 
leaflet. 1x 
telephone 
call 
(unknown 
duration) 
PNE 
0.5h 
 
Contr
ol 
0.5h 
0.5h 
individual 
Self-
managem
ent 
techniques
. Leaflet 
about 
Fibromy
algia 
patients 
can 
understa
nd and 
rememb
er PNE. 
Univer
sity 
faciliti
es. 
Bruss
els, 
Belgiu
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an 
Colleg
e of 
Rheum
atology 
1990 
criteria
62.  
18-65 
years 
of age. 
 
Baselin
e pain 
as 
mean 
% = 
61.3% 
Duratio
n of 
pain in 
mean 
(SD) 
to answer 
questions 
about the 
leaflet, 
motivate to 
read leaflet 
and 
encourage 
application 
of material 
to life. 
 
activity 
managem
ent. 1x 
telephone 
call 
(unknown 
duration) 
to answer 
questions 
about the 
leaflet, 
motivate to 
read leaflet 
and 
encourage 
application 
of material 
to life. 
 
PNE 
resulted 
in less 
worrying 
in the 
short-
term, 
and 
long-
term 
improve
ments in 
vitality, 
physical 
functioni
ng, 
mental 
health, 
and 
general 
health 
perceptio
ns. No 
significa
nt 
m. 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
 65 
months 
= 136 
(71) 
changes 
establish
ed in 
pain 
catastrop
hising, 
hypervigi
lance, or 
kinesiop
hobia. 
Pain 
pressure 
threshold
s were 
unchang
ed. A 
positive 
effect on 
endogen
ous pain 
inhibition 
at 3-
month 
follow up 
was 
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found. 
Galla
gher, 
McAu
ley 
and 
Mosel
ey 
20131
1  
RC
T 
N = 
79 
39% 
M 
43.5 
18-75 
years 
of age 
with 
pain 
that 
had 
been 
sufficie
nt to 
disrupt 
their 
activitie
s of 
daily 
living 
for 
more 
than 
the 
previou
s 3 
months
80-page 
booklet 
divided 
into 11 
sections - 
Metaphors 
and stories 
to help 
understan
d the 
biology of 
pain 
 
Unkn
own 
80-page 
booklet 
divided 
into 11 
sections - 
Advice 
about 
managing 
pain (The 
back book 
and 
Manage 
your pain) 
 
Written 
material 
using 
metapho
rs to 
explain 
key 
biologica
l 
concepts 
increase
d 
knowled
ge of 
pain 
biology 
and 
decrease
d 
catastrop
hic 
thought 
processe
Unkno
wn 
Unkno
wn 
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. 
 
Baselin
e pain 
as 
mean 
% = 
65% 
 
Duratio
n of 
pain in 
mean 
(SD) 
months 
= 28 
(19.5) 
s about 
pain and 
injury 
when 
compare
d to 
material 
that 
presente
d 
biopsych
osocial 
advice 
for pain 
manage
ment. 
Pires, 
Cruz 
and 
Caeir
o, 
20154
RC
T 
N = 
62 
35% 
M 
51 
Low 
back 
pain >3 
months 
duratio
n +/- 
2x 1.5h 
Group 
PNE.  
12 
sessions 
of aquatic 
PNE 
3h 
 
Contr
ol 3h 
12 
sessions 
of aquatic 
exercise 
over 6 
weeks. 30-
PNE is a 
clinically 
effective 
addition 
to 
aquatic 
Outpa
tient 
clinic. 
Portug
al  
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1  leg 
pain. 
18-65 
years 
of age. 
 
Baselin
e pain 
as 
mean 
% = 
42.9% 
 
Duratio
n of 
pain in 
mean 
(SD) 
months 
= 
unkno
wn 
exercise 
over 6 
weeks. 30-
50m each 
session. 
 
 
50m each 
session. 
 
exercise. 
The 
addition 
of PNE 
resulted 
in 
statistical
ly 
significa
nt 
reduction 
in pain 
intensity 
at 3-
month 
follow 
up. No 
statistical
ly 
significa
nt 
differenc
es were 
found for 
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pain 
intensity 
at 6 
weeks 
follow up 
or 
functiona
l 
disability 
at either 
follow 
up. 
Louw 
et al. 
2014/
1627,2
8  
RC
T 
N = 
67 
46% 
M 
49.6 
Patient
s with 
lumbar 
radicul
opathy, 
schedu
led for 
lumbar 
surgery
. 18-65 
years 
of age. 
0.5h 
individual 
PNE. 
PNE 
booklet 
"your 
nerves are 
having 
back 
surgery" & 
Lumbar 
surgery + 
PNE 
0.5h 
 
Contr
ol 0 
Lumbar 
surgery 
alone + 
usual care 
 
Providin
g a 
single 
PNE 
session 
to 
patients 
prior to 
lumbar 
surgery 
(LS) 
results in 
7 
Clinic
al 
sites 
in the 
USA. 
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Baselin
e pain 
as 
mean 
% = 
48.4% 
 
Duratio
n of 
pain in 
mean 
(SD) 
months 
= 3 
(7.5) 
usual care 
 
significa
nt 
reduction 
in 
healthcar
e costs 
3-years 
after LS.   
Tellez
-
Garci
a et 
al. 
20154
8  
RC
T 
N = 
12 
33% 
M 
36.5 
Chroni
c non-
specific 
low 
back 
pain ≥3 
months 
defined 
2 x 0.5h 
individual 
PNE. + 
written 
information 
about PNE 
as 
PNE 
1h 
 
Contr
ol 0 
Trigger 
point-dry 
needling, 
1x per 
week for 3 
weeks.  
 
Trigger 
point dry 
needling 
is 
effective 
for 
improvin
g pain, 
Unkno
wn 
Unkno
wn 
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as pain 
sympto
ms 
localise
d 
below 
costal 
margin 
and 
over 
the 
gluteus 
area. 
18-65 
years 
of age. 
Withou
t 
referral 
into 
lower 
extremi
ty >1 
year. 
≥4 
homework 
 
Trigger 
point-dry 
needling, 
1x per 
week for 3 
weeks.  
 
disability, 
kinesiop
hobia 
and 
widespre
ad 
pressure 
pain 
sensitivit
y at short 
term in 
individua
ls with 
mechani
cal LBP. 
The 
inclusion 
of PNE 
exerts a 
greater 
impact 
for 
decreasi
ng 
kinesiop
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points 
on 
RMDQ. 
Not 
receive
d 
physio 
past 6 
months
. At 
least 1 
active 
trigger 
point 
reprod
ucing 
their 
sympto
ms 
diagno
sed 
accordi
ng to 
criteria 
outline
hobia. 
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d by 
Simons 
et al.   
 
Baselin
e pain 
as 
mean 
% = 
65% 
 
Duratio
n of 
pain in 
mean 
(SD) 
months 
= 18 
(8.5) 
Lluch 
et al. 
20182
5  
RC
T 
N = 
54 
37% 
M 
Sympt
omatic 
knee 
osteoar
Individual 
PNE 1x 
50-60m & 
3 x 20-
PNE 
2.17h 
 
Contr
Individual 
Biomedical 
education 
1x 50-60m 
A 
preopera
tive 
treatmen
Ortho
paedic 
surger
y 
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70.3 
 
 
thritis 
(Diagn
osed 
accordi
ng to 
the 
Americ
an 
Colleg
e of 
Rheum
atology 
criteria
1 of >3 
months 
duratio
n and 
schedu
led to 
underg
o total 
knee 
replace
ment.  
30m + 
read 
Explicano 
el dolor5  
Knee joint 
mobilisatio
ns once a 
week for 4 
week, 3 
sets of 10. 
Self-
mobilisatio
ns 4 sets 
20 reps 
per day. 
2 months  
 
Total knee 
replaceme
nt 1 month 
after 
finishing 
education 
ol 
2.17h 
& 3 x 20-
30m. 
Knee joint 
mobilisatio
ns once a 
week for 4 
week, 3 
sets of 10. 
Self-
mobilisatio
ns 4 sets 
20 reps 
per day. 
 
Total knee 
replaceme
nt 1 month 
after 
finishing 
education 
and 
mobilisatio
ns. 
t for 
people 
with 
knee 
osteoart
hritis 
combinin
g PNE 
with 
knee 
joint 
mobilisat
ions did 
not 
produce 
any 
additiona
l benefits 
in knee 
pain and 
disability 
and 
central 
sensitisa
tion 
servic
e of a 
hospit
al. 
Spain.  
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Baselin
e pain 
as 
mean 
% = 
58% 
 
Duratio
n of 
pain in 
mean 
(SD) 
months 
= 93 
(67.8) 
and 
mobilisatio
ns. 
measure
s when 
compare
d with 
that 
combinin
g 
biomedic
al 
educatio
n with 
knee 
joint 
mobilisat
ion. 
Superior 
effects 
were 
observed 
in the 
PNE and 
knee 
joint 
mobilisat
ion 
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group for 
psychos
ocial 
variables 
related 
to pain 
catastrop
hising 
and 
kinesiop
hobia.  
Bode
s et 
al. 
20182  
RC
T 
N = 
56 
27.3
% M 
47 
Non-
specific 
CLBP 
for 
≥6 
months 
 
20-75 
years 
of age 
 
Baselin
Therapeuti
c exercise 
– including 
motor 
control 
exercises 
for the 
lumbar 
spine, 
stretches, 
and 
aerobic 
exercise. 
PNE 
1.33h 
 
Contr
ol 0  
Therapeuti
c exercise 
– including 
motor 
control 
exercises 
for the 
lumbar 
spine, 
stretches, 
and 
aerobic 
exercise. 
A 
program 
of PNE 
combine
d with 
therapeu
tic 
exercise 
is more 
effective 
in 
reducing 
pain, 
Privat
e 
clinic 
and 
univer
sity.  
Spain. 
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e pain 
as 
mean 
% = 
79% 
 
Duratio
n of 
pain in 
mean 
(SD) 
months 
= 
Unkno
wn 
To be 
completed 
daily. 
 
Group (4-6 
patients) 
PNE 2x 30 
to 50 
minutes 
plus a 
leaflet. 
To be 
completed 
daily. 
 
disability, 
and pain 
catastrop
hising 
compare
d with 
therapeu
tic 
exercise 
alone in 
patients 
with 
CLBP.  
 
Malfli
et et 
al. 
20183
0  
RC
T 
N = 
120 
39.2
% M 
39.8 
Non-
specific 
chronic 
spinal 
pain 
(neck 
and 
lower 
back) 
3 PNE 
sessions 
1. 0.5-1h 
group 
(maxim
um of 6 
patient
s). 
Informa
tion 
booklet 
provide
d at the 
end. 
2. ~0.63h 
home-
PNE 
1.88h 
 
Contr
ol 
1.88h 
3 
biomedical 
education 
sessions 
1. 0.5-1h 
group 
(maxim
um of 6 
patient
s). 
Informa
tion 
booklet 
provide
PNE, 
and not 
neck/bac
k school 
educatio
n, is able 
to 
improve 
kinesiop
Univer
sity 
hospit
als in 
Ghent 
and 
Bruss
els, 
Belgiu
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at least 
3 days 
a week 
for at 
least 3 
months 
since 
the first 
sympto
ms.  
 
18-65 
years 
of age 
 
Baselin
e pain 
as 
mean 
% = 
50.65 
 
Duratio
based 
online 
e-
learnin
g 
module 
containi
ng 3 
explan
atory 
videos 
and 
questio
ns 
about 
pain.  
3. 0.5 
Individu
al 
educati
on. 
Focus 
on 
patient
s‟ 
person
al 
needs 
followin
g 
difficulti
es with 
session 
2. 
Focus 
on the 
applicat
ion of 
knowle
dge to 
particip
ants 
life. 
d at the 
end. 
2. ~0.63h 
Home-
based 
online 
e-
learnin
g 
module 
containi
ng 3 
explan
atory 
videos 
3. 0.5 
Individu
al. 
Focus 
on 
patient
s‟ 
person
al 
needs 
followin
g 
difficulti
es with 
session 
2. 
Focus 
on the 
applicat
ion of 
knowle
dge to 
particip
ants 
life. 
hobia, 
beliefs 
regardin
g the 
negative 
impact of 
the 
illness 
on 
quality of 
life and 
functiona
l 
capacity, 
and 
beliefs 
regardin
g the 
chronicit
y of pain 
and the 
time 
scale of 
illness 
symptom
m.  
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n of 
pain in 
mean 
(SD) 
months 
= 82 
(143.2
5) 
s. 
However
, none of 
the 
educatio
nal 
program
s of this 
study 
were 
able to 
decrease 
the 
participa
nts 
perceive
d 
disability 
due to 
pain. 
Neverthe
less, as 
kinesiop
hobia is 
generally 
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consider
ed to be 
a strong 
predictor 
and 
mediator 
of 
chronic 
pain, 
PNE is 
preferred 
as the 
educatio
nal 
approac
h for 
people 
with non-
specific 
chronic 
spinal 
pain.  
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Abbreviations: RCT, randomised controlled trial; LBP, low back pain; CLBP, chronic 
low back pain; PNE, pain neuroscience education; PMP, pain management 
programme; CFS, chronic fatigue syndrome; SD, standard deviation. USA, United 
States of America; RMDQ, Roland Morris Disability 
Questionnaire.http://www.rmdq.org/ 
 
Table 6 Characteristics of included studies - qualitative component 
Study/Cou
ntry 
Methodology/Me
thods 
Participants Phenomena of 
interest 
Findings 
Robinson 
et al. 
201642 
UK  
Interpretive 
phenomenologic
al analysis.  
 
Semi-structured 
individual 
interviews using 
open questions, 
post only. 
N = 10 adults 
with chronic 
musculoskeletal 
pain recruited 
from an NHS 
Pain Clinic.  
Mean age = 48.5 
years (Range = 
28-64)  
60% Male.  
Mean duration of 
pain = 9.2 years 
(Range = 2-32). 
Following a 
single 2h 
group PNE 
session: to 
explore the 
experience of 
PNE for 
people with 
chronic pain 
and to gain 
insight into 
their 
understanding 
of their pain 
Three themes 
emerged: 
perceived 
relevance for 
the individual 
participant; 
perceived 
benefits for the 
individual 
participant; and 
evidence of 
reconceptualis
ation. Within 
these themes 
there were 
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3 unemployed, 3 
employed, 1 self-
employed, 1 
retired, 2 sick-
leave. 
after PNE. examples of 
positive and 
negative 
experiences, 
the latter 
manifesting as 
lack of 
relevance, lack 
of benefit and 
lack of 
evidence of 
reconceptualis
ation. An 
interlinking 
narrative was 
the importance 
of relevance.  
King et al. 
201624 
UK  
Interpretive 
phenomenologic
al analysis.  
 
Semi-structured 
individual 
interviews using 
N = 7 adults with 
chronic 
musculoskeletal 
pain recruited 
from an NHS 
Pain Clinic. 
Mean duration of 
Following a 
single 2h 
group PNE 
session: to 
investigate the 
degree and 
nature of 
Themes 
described 
variable 
degrees of 
reconceptualis
ation, including 
none; people‟s 
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open questions, 
pre and post. 
pain = 9.7 years 
(Range = 2-26 
years). 
people‟s 
reconceptualis
ation of their 
own chronic 
pain following 
PNE. 
beliefs about 
their pain 
before PNE as 
barriers to or 
facilitators of 
reconceptualis
ation; and the 
influence of 
reconceptualis
ation on clinical 
benefits of 
PNE.  
Wijma et 
al. 201761 
The 
Netherland
s  
Grounded 
Theory.  
 
Semi-structured 
interviews using 
open questions. 
Focus group with 
healthcare 
professionals 
Interviews 
N = 15 recruited 
from a 
transdisciplinary 
outpatient 
treatment centre. 
Mean age = 47 
(Range 18-62) 
47% Male 
Mean duration of 
pain = 7 years 
Explore the 
experiences of 
patients with 
chronic pain 
who recently 
received PNE 
in a 
transdisciplinar
y setting. 
Several topics 
and subthemes 
emerged. The 
pre-PNE 
phase, in which 
respondents 
met the 
healthcare 
professionals 
during a board 
intake. The 
second topic, a 
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(Range = 23-0.5) 
 
Focus group 
6 members of 
Transcare: one 
general 
practitioner, two 
psychologists, 
two 
physiotherapists, 
and one 
researcher. 
50% Male 
Mean age = 46 
years (Range = 
37-57) 
Mean experience 
= 22 years 
(Range = 16-34) 
Two had higher 
professional 
education with 
postgraduate 
comprehensibl
e PNE, 
comprised of 
understandable 
explanation, 
and the 
interaction 
between the 
physiotherapist 
and 
psychologist. 
The third topic 
involved the 
outcomes of 
PNE, with the 
subthemes 
awareness, 
finding peace 
of mind, and 
fewer 
symptoms. The 
final topic, 
scepticism, 
contained 
doubt towards 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
 85 
qualification. Two 
had a University 
postgraduate 
qualification. Two 
had a university 
postgraduate 
qualification and 
PhD.  
the diagnosis 
and PNE, 
disagreement 
with diagnosis 
and PNE, and 
PNE can be 
confronting.  
King et al. 
201823 
UK  
Theoretical 
thematic 
analysis.  
 
Semi-structured 
individual 
interviews using 
open questions, 
pre and post. 
N = 12 adults 
(≥18 years) and 
had a primary 
complaint of 
chronic (>6 
months duration) 
lower back pain 
(+/- leg 
symptoms) of a 
neuro/musculosk
eletal origin. 
Recruited from 
an NHS Pain 
Clinic. 
Mean age = 48 
years (Range = 
Following a 
single 2h 
group PNE 
session: to 
investigate the 
extent, and 
nature, of 
people‟s 
reconceptualis
ation of their 
CLBP 
following PNE. 
 
The a priori 
themes – 
degrees of 
reconceptualis
ation, personal 
relevance, 
importance of 
prior beliefs 
and perceived 
benefit of PNE 
– were all 
clearly 
identifiable 
within the data 
and did indeed 
provide a good 
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25-72). 
42% Male. 
Mean duration of 
pain = 10 years 4 
months (Range = 
8 months-26 
years). 
3 unemployed, 6 
employed, 3 
retired. 
Participants 
ranged from 
holding no 
qualifications to 
holding a BSc 
(Hons) degree. 
description of 
participants‟ 
accounts. One 
participant 
reported 
distress during 
the session 
which is the 
first reporting 
of an adverse 
event 
associated with 
PNE in the 
literature. 
Abbreviations: UK, United Kingdom; NHS, National Health Service; PNE, pain 
neuroscience education; h, hour. 
 
